|
|
|
Volumn 23, Issue 1 SUPPL. 1, 1996, Pages 4-9
|
|
Single-agent paclitaxel for the treatment of breast cancer: An overview
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOXORUBICIN;
MITOMYCIN C;
PACLITAXEL;
VINBLASTINE;
ADULT;
AGED;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERANCE;
FEMALE;
HIGH RISK POPULATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE II;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
MIDDLE AGED;
MULTICENTER STUDIES;
PACLITAXEL;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0029922953
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (47)
|
|
References (0)
|
